Ipsogen
Marseille Cedex, FR· latest recorded location
IPSOGEN is named on 1 US grants and 6 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 1
- Published applications
- 6
- Inventors
- 20
- Granted in 2026 so far
- 0
- Most recent grant
- 30 Sep 2008
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
By publication year.
Technology areas
Share of 7 documents
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7
- A61PTherapeutic uses of medicines3
- G01NInvestigating or analysing materials by determining their chemical or physical properties3
- C07KPeptides1
- C12NMicroorganisms or enzymes1
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the1
- Y02ATechnologies for adaptation to climate change1
Recent patents
- Gene expression profiling of primary breast carcinomas using arrays of candidate genes28 Mar 2013US 2013/0079234 A1
- Asxl1 as a new diagnostic marker of myeloid neoplasms7 Mar 2013US 2013/0059301 A1
- Methods for identifying erbb2 alteration in tumors6 Oct 2011US 2011/0244459 A1
- Gene expression profiling of primary breast carcinomas using arrays of candidate genes14 Apr 2011US 2011/0086765 A1
- Breast cancer expression profiling20 Jan 2011US 2011/0014191 A1
Most cited
By later US patents